Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy-Reference-Cited by-同舟云学术

Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy

Published:2013-11 Issue:17 Volume:49 Page:3648-3657
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Harland Stephen,Staffurth John,Molina Arturo,Hao Yanni,Gagnon Dennis D.,Sternberg Cora N.,Cella David,Fizazi Karim,Logothetis Christopher J.,Kheoh Thian,Haqq Christopher M.,de Bono Johann S.,Scher Howard I.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. Quality of life associated with treatment of castration-resistant prostate cancer: a review of the literature;Moul;Cancer Invest,2012

2. Quality of life findings from a multicenter, multinational, observational study of patients with metastatic hormone-refractory prostate cancer;Sullivan;Qual Life Res,2007

3. End points and outcomes in castration-resistant prostate cancer: from clinical trials to clinical practice;Scher;J Clin Oncol,2011

4. Efficient assessment of the most important symptoms in advanced prostate cancer: the NCCN/FACT-P symptom index;Victorson;Psychooncology,2011

5. The quality of life of patients with newly diagnosed M1 prostate cancer: experience with EORTC clinical trial 30853;Da Silva;Eur J Cancer,1996

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing assessments of quality of life in contemporary prostate cancer clinical trials;Cancer;2024-07-27

2. Contemporary Systemic Therapy Intensification for Prostate Cancer: A Review for General Practitioners in Oncology;Current Oncology;2024-02-15

3. Quality of life for androgen receptor targeted agents in patients with metastatic castration resistant prostate cancer;Bratislava Medical Journal;2024

4. Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agents;Annals of Oncology;2023-06

5. Cardiovascular Complications in Patients with Prostate Cancer: Potential Molecular Connections;International Journal of Molecular Sciences;2023-04-10